6.12
-0.24(-3.77%)
Currency In USD
| Previous Close | 6.36 |
| Open | 6.25 |
| Day High | 6.48 |
| Day Low | 6.12 |
| 52-Week High | 11.78 |
| 52-Week Low | 2.22 |
| Volume | 8,971 |
| Average Volume | 221,106 |
| Market Cap | 67.97M |
| PE | -8.62 |
| EPS | -0.71 |
| Moving Average 50 Days | 6.49 |
| Moving Average 200 Days | 5.79 |
| Change | -0.24 |
If you invested $1000 in Nutriband Inc. (NTRB) since IPO date, it would be worth $1,066.2 as of March 14, 2025 at a share price of $6.12. Whereas If you bought $1000 worth of Nutriband Inc. (NTRB) shares 3 years ago, it would be worth $2,147.37 as of March 14, 2025 at a share price of $6.12.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.
GlobeNewswire Inc.
Feb 21, 2025 12:00 PM GMT
ORLANDO, Fla., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced that it received the Certificate of Registration from the United States Patent and Tr
Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
GlobeNewswire Inc.
Feb 13, 2025 12:00 PM GMT
Nutriband and Kindeva formalize exclusive product development partnership and long-term commitment based on shared development costs in exchange for milestone payments Nutriband is partnering with Kindeva Drug Delivery to develop Aversa™ Fentanyl whi
Nutriband Inc. Announces Olympian Anastasia Nichita to Advisory Board
GlobeNewswire Inc.
Feb 11, 2025 2:00 PM GMT
ORLANDO, Fla., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (the “Company”)(NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced World and European Wrestling Gold medalist and Olympic Silver medalist A